Powered by lexis nexis

Advanced Cardiac Therapeutics Announces $45 Million in New Funding to Advance Innovative Treatment for Heart Disease

May 02, 2017 - Business Wire
Board and Executive Moves-Investments

Advanced Cardiac Therapeutics, Inc., ("ACT" or the "Company"), a medical device company focused on developing a next-generation ablation catheter to treat cardiac arrhythmias including atrial fibrillation, today announced $45 million in new equity funding led by Ajax Health ("Ajax") alongside existing investor New Enterprise Associates ("NEA") and new investor Questa Capital Management ("Questa").

This Smart News Release features multimedia. View the full release here: http://www.businessw...